24MAY

Ship hantavirus cluster is winding down

3 min read

16:06UTC

WHO bulletin DON604 put the MV Hondius Andes-virus cluster at an effective reproduction number of 0.7 on 22 May, with 13 cases and matching genomes confirming a single spillover. The 42-day all-clear window closes in mid-June.

← Back to Ebola triples, response misfires Jump to analysis ↓

ScienceDeveloping

Key takeaway

The MV Hondius hantavirus cluster is winding down at an Rt of 0.7, with an all-clear due mid-June.

WHO bulletin DON604 put the effective reproduction number of the MV Hondius Andes-virus cluster at 0.7 as of 22 May⁠¹. The MV Hondius is a Dutch-flagged Antarctic expedition cruise ship; Andes virus is the only hantavirus known to spread person to person, which is why this cluster drew formal WHO tracking at all. The effective reproduction number, or Rt, is the average number of further people each case infects; a value below one means an outbreak shrinks on its own.

The cluster added just one case since 24 May, reaching 13 in total. Near-identical genome sequences across patients confirm a single rodent-to-human spillover rather than scattered introductions⁠². That genomic match is what rules out independent reintroductions, the signature that lets epidemiologists declare a cluster finished rather than merely paused.

The WHO holds the global risk at low. The 42-day quarantine window for the highest-risk contacts, set at twice the longest plausible incubation period, closes in mid-June; if no new case appears, the WHO can formally declare the outbreak over. Saying plainly that an outbreak is ending is as much the calibration job as flagging one that is not.

Deep Analysis

In plain English

Andes virus is an unusual type of hantavirus, a group of diseases spread by rodents, because it is the only one that can also spread between people through close contact. Thirteen people WHO travelled on the MV Hondius expedition cruise ship contracted Andes virus. Three died. The good news from WHO's 28 May bulletin is that the outbreak appears to be winding down. The effective reproduction number (Rt) has been measured at 0.7, which means each sick person is, on average, infecting fewer than one other person. When Rt stays below 1, an outbreak fades out naturally. The last significant exposure window closes around mid-June, when the 42-day monitoring period for the highest-risk contacts ends. Health authorities in 12 countries have been tracking contacts of infected passengers since the ship docked at Rotterdam in May.

What could happen next?

Opportunity
Near-identical genome sequences from 13 cases confirming a single-spillover origin will provide the cleanest dataset available for modelling Andes virus person-to-person transmission risk in closed travel environments, directly informing future cruise-ship and expedition-vessel biosafety protocols.

Source Landscape

This story draws on neutral-leaning sources

Primary parallel: The 1996 El Bolsón Andes hantavirus cluster in Patagonia, Argentina, was the first documented case of person-to-person hantavirus transmission. A 21-year-old woman developed hantavirus cardiopulmonary syndrome (HCPS) after caring for her husband; subsequent investigation found that 16 of 19 cases had epidemiological links to a single index patient through close-contact caregiving, not rodent exposure.

The cluster had an effective reproduction number estimated at approximately 0.7 to 0.9, structurally similar to the MV Hondius 2026 figure, and burned out naturally after two to three transmission generations. El Bolsón established that Andes virus is the only hantavirus with proven person-to-person spread, which is why the CDC's HAN00528 advisory required airborne infection isolation rather than rodent-exposure precautions alone.

Counter-parallel: The 2012 MERS-CoV (Middle East Respiratory Syndrome coronavirus) ship-adjacent cluster in South Korea showed that a respiratory pathogen introduced into a closed travel environment (hotel in that case, ship in the Hondius case) can produce an Rt well above 1 if healthcare settings amplify transmission.

The key structural difference is MERS's respiratory droplet spread versus Andes virus's body-fluid and close-contact transmission mechanism: Andes does not transmit efficiently in low-contact environments.

Consensus view: Trevor Bedford at the Fred Hutchinson Cancer Center (genomic epidemiology) has written on Andes virus cluster analysis that near-identical genome sequences across a passenger cohort are the strongest available signal that an outbreak originated from a single rodent-to-human spillover event rather than from human-to-human transmission during the voyage.

DON604's confirmation of near-identical sequences across 13 MV Hondius cases, combined with an effective reproduction number (Rt) of 0.7, provides genomic and epidemiological evidence that the cluster is self-limiting from a single source exposure. An Rt below 1 means each case, on average, infects fewer than one new person.

Counter-view: ECDC's surveillance team noted in their 12 May update a three-case discrepancy between their count and WHO's, reflecting different national-level case-definition thresholds.

At least one national health authority in the EU has applied a broader probable-case definition that captures individuals with lower viral loads WHO would not meet WHO's confirmed-case threshold. Under the broader definition, the effective reproduction number could differ from the 0.7 WHO reports, because denominator assumptions change when you include probable cases alongside confirmed ones.

Key tension: Whether the 42-day quarantine window for highest-risk contacts closes clean in mid-June, or whether any late-onset cases emerge in the final observation period that revise the cluster's Rt estimate upward.

Sources:World Health Organization

Mentions:World Health Organization →MV Hondius →DON 600 →ECDC →HCPS →South Korea →Patagonia →HAN00528 →Argentina →CDC →Andes virus →Trevor Bedford →El Bolsón →MERS-CoV →

First Reported In

Update #5 · Ebola money arrives, the cure does not

World Health Organization· 2 Jun 2026

Read original →

Causes and effects

Caused by

Hondius hantavirus cluster hits 12 cases

DON604's 13-case total is an increment from the 12-case cluster recorded at ID:3601, confirming the downward trajectory.

Occurred 24 May 2026

Read story →

This Event

Ship hantavirus cluster is winding down

An Rt below one and a single-spillover genomic signature let epidemiologists call this outbreak over with confidence rather than hope.

Different Perspectives

IGWG co-chair Tovar da Silva Nunes

The Brazilian co-chair closed the eighth pathogen-sharing session on 18 September without an agreed annex text, the second session in a row to end that way. He presented the outcome as continued commitment, with adoption due at the World Health Assembly in May 2027.

Fraport

The Frankfurt Airport operator has told staff to watch for fever, hessenschau reported, after six airport workers caught malaria. Germany does not require insecticide spraying of arriving aircraft cabins, and parasite genotyping to trace the source is due at the end of October.

European Centre for Disease Prevention and Control

ECDC reported the eight Frankfurt Airport malaria cases on 18 September and considers repeated arrivals of infected mosquitoes on aircraft likely. It has not ruled out local mosquitoes, and awaits genotyping due at the end of October.

Pan American Health Organization

PAHO counted 53,957 measles cases in the Americas by 19 September and is supporting Peru's response in Puno and Arequipa. It warns that October's Señor de los Milagros festivities and Pope Leo XIV's November visit could increase transmission.

Bangladesh Directorate General of Health Services

The DGHS recorded 1,030 measles-related deaths and 172,720 suspected cases by 14 September, after a campaign that reached 19.75 million children. Its disease-control director, Halimur Rashid, said further vaccination rounds were expected within two weeks.

Minapharm

The Egyptian drugmaker and its Berlin subsidiary ProBioGen were awarded up to US$16.5m by CEPI on 27 August to take a Bundibugyo vaccine into a Phase 1 trial in Africa. Final manufacture is planned for Cairo, making it CEPI's first Bundibugyo candidate with an African producer.